Cost-Benefit Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in Elderly over 75 Years Old
碩士 === 高雄醫學大學 === 醫務管理暨醫療資訊學系碩士在職專班 === 105 === Abstract Background： Streptococcus pneumoniae infections in elderly induce serious diseases, mortality and a lot of cost. The 23-valent pneumococcal polysaccharide vaccine is recommended in elderly for preventing associated disease. The study purpo...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2017
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/83422579698075679332 |